Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed
Search for other papers by Feng Gu in
Google Scholar
PubMed
Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed
Search for other papers by Thierry C Brue in
Google Scholar
PubMed
Search for other papers by Maria Fleseriu in
Google Scholar
PubMed
Search for other papers by Ilan Shimon in
Google Scholar
PubMed
Search for other papers by Aart J van der Lely in
Google Scholar
PubMed
Search for other papers by Shoba Ravichandran in
Google Scholar
PubMed
Search for other papers by Albert Kandra in
Google Scholar
PubMed
Search for other papers by Alberto M Pedroncelli in
Google Scholar
PubMed
Search for other papers by Annamaria A L Colao in
Google Scholar
PubMed
Introduction Acromegaly is a chronic endocrine disorder typically caused by a benign tumor of the pituitary gland ( 1 ), which hypersecretes growth hormone (GH) with subsequent secretion of insulin-like growth factor I (IGF-I). Long
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed
Search for other papers by Diego Ferone in
Google Scholar
PubMed
Search for other papers by Jens Sandahl Christiansen in
Google Scholar
PubMed
Search for other papers by David Gilfoyle in
Google Scholar
PubMed
Search for other papers by Eva Dam Christoffersen in
Google Scholar
PubMed
Search for other papers by Eva Mortensen in
Google Scholar
PubMed
Search for other papers by Jonathan A Leff in
Google Scholar
PubMed
Search for other papers by Michael Beckert in
Google Scholar
PubMed
with insulin-like growth factor 1 (IGF1), leads to abnormal body composition and metabolism as well as psychological impairment ( 1 , 2 ). Left untreated, AGHD is associated with decreased bone mineral density, increased risk of cardiovascular
Search for other papers by Adrian F Daly in
Google Scholar
PubMed
Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed
Search for other papers by Daniela Betea in
Google Scholar
PubMed
Search for other papers by Jean-François Bonneville in
Google Scholar
PubMed
Department of Pathological Cytology and Anatomy, Foch Hospital, Paris, France
Search for other papers by Chiara Villa in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
Search for other papers by Beatrice Waser in
Google Scholar
PubMed
Search for other papers by Jean-Claude Reubi in
Google Scholar
PubMed
Search for other papers by Catherine Waeber Stephan in
Google Scholar
PubMed
Search for other papers by Emanuel Christ in
Google Scholar
PubMed
Search for other papers by Albert Beckers in
Google Scholar
PubMed
pasireotide test diminished GH from a baseline of 9.5 to 3.3 ng/mL after 4 h. She was started on pasireotide LAR 20 mg i.m. every 4 weeks and this was up-titrated to 60 mg over 12 months and during this time her IGF-1 was normalized (203 ng
Search for other papers by Xiaonan Guo in
Google Scholar
PubMed
Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Search for other papers by Xiaorui Lyu in
Google Scholar
PubMed
Search for other papers by Hanyuan Xu in
Google Scholar
PubMed
Search for other papers by Huijuan Zhu in
Google Scholar
PubMed
Search for other papers by Hui Pan in
Google Scholar
PubMed
Search for other papers by Linjie Wang in
Google Scholar
PubMed
Search for other papers by Hongbo Yang in
Google Scholar
PubMed
Search for other papers by Fengying Gong in
Google Scholar
PubMed
Introduction Growth hormone (GH) is a significant regulator of growth and metabolism ( 1 ). In the liver, GH stimulates the synthesis and secretion of insulin-like growth factor 1 (IGF-1) ( 2 ). The GH/IGF-1 axis can regulate hepatic glucose
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Mette Marie Baunsgaard in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Sophie Lind Helligsoe in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Louise Tram Henriksen in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Torben Stamm Mikkelsen in
Google Scholar
PubMed
Search for other papers by Michael Callesen in
Google Scholar
PubMed
Search for other papers by Britta Weber in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Henrik Hasle in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Niels Birkebæk in
Google Scholar
PubMed
OD Roswall J Körner A Obermayer-Pietsch B Hübener C Dahlgren J Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Search for other papers by Sylvain Roumeau in
Google Scholar
PubMed
Search for other papers by Joannice Thevenon in
Google Scholar
PubMed
CHU Clermont-Ferrand, Service de Biostatistiques, Clermont-Ferrand, France
Search for other papers by Lemlih Ouchchane in
Google Scholar
PubMed
CHU de Clermont-Ferrand, Service d’Endocrinologie, Diabétologie et Maladies Métaboliques, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Salwan Maqdasy in
Google Scholar
PubMed
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Marie Batisse-Lignier in
Google Scholar
PubMed
CHU Clermont-Ferrand, Inserm CIC 1405, Clermont-Ferrand, France
Search for other papers by Christian Duale in
Google Scholar
PubMed
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
CHU de Clermont-Ferrand, Service de chirurgie maxillo-faciale, Clermont-Ferrand, France
Search for other papers by Nathalie Pham Dang in
Google Scholar
PubMed
Search for other papers by Philippe Caron in
Google Scholar
PubMed
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Igor Tauveron in
Google Scholar
PubMed
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
Université Clermont Auvergne, Faculté de Chirurgie Dentaire, Clermont-Ferrand, France
Search for other papers by Laurent Devoize in
Google Scholar
PubMed
aspects of the oral condition in this pathology have not been properly described. Indeed, the consequences of elevated GH and IGF-1 on gingivae is debated. Some observations describe a gingival enlargement in acromegalic patients ( 8 ), which is known to
Search for other papers by Imane Benabbad in
Google Scholar
PubMed
Search for other papers by Myriam Rosilio in
Google Scholar
PubMed
Search for other papers by Maité Tauber in
Google Scholar
PubMed
Search for other papers by Emmanuel Paris in
Google Scholar
PubMed
Search for other papers by Anne Paulsen in
Google Scholar
PubMed
Search for other papers by Lovisa Berggren in
Google Scholar
PubMed
Search for other papers by Hiren Patel in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Robert-Debré, Department of Pediatric Endocrinology and Diabetology, and Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Paris, France
Search for other papers by Jean-Claude Carel in
Google Scholar
PubMed
Search for other papers by the Phoenix Study Group in
Google Scholar
PubMed
( 17 ) and confirmed by a centralised bone age reading. Patients were excluded if they had GH deficiency (defined as peak GH ≤20 IU/L in each of two stimulation tests), had insulin-like growth factor (IGF)-I SDS >3, were born small for gestational age
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by B Shahida in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Malmö, Sweden
Search for other papers by P Sahlstrand Johnson in
Google Scholar
PubMed
Search for other papers by R Jain in
Google Scholar
PubMed
Department of Plastic Surgery, Skåne University Hospital, Malmö, Sweden
Search for other papers by H Brorson in
Google Scholar
PubMed
Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden
Search for other papers by P Åsman in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by M Lantz in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by T Planck in
Google Scholar
PubMed
as an autoantigen and is expressed by both preadipocytes and adipocytes in orbital tissue ( 1 , 2 ) as well as in the thyroid. Other autoantigens, such as the insulin-like growth factor 1 (IGF-1) receptor have been suggested to be involved in the
School of Medicine, Western Sydney University, Sydney, Australia
Search for other papers by Prishila Fookeerah in
Google Scholar
PubMed
Westmead Clinical School, University of Sydney, Sydney, Australia
Search for other papers by Winny Varikatt in
Google Scholar
PubMed
Westmead Clinical School, University of Sydney, Sydney, Australia
Search for other papers by Meena Shingde in
Google Scholar
PubMed
Department of Neurosurgery, Westmead Hospital, Sydney, Australia
Search for other papers by Mark A J Dexter in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Sydney, Australia
Search for other papers by Mark McLean in
Google Scholar
PubMed
1) for somatotrophs, lactotrophs and thyrotrophs). The 2022 WHO Classification of Pituitary Tumours recognises two relatively rare exceptions to this rule: (i) multiple synchronous PitNETs; separate tumour populations within a single macroscopic
Search for other papers by Danielle Christine Maria van der Kaay in
Google Scholar
PubMed
Search for other papers by Anne Rochtus in
Google Scholar
PubMed
Search for other papers by Gerhard Binder in
Google Scholar
PubMed
Search for other papers by Ingo Kurth in
Google Scholar
PubMed
Search for other papers by Dirk Prawitt in
Google Scholar
PubMed
Search for other papers by Irène Netchine in
Google Scholar
PubMed
Department of Endocrinology at Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Anita C S Hokken-Koelega in
Google Scholar
PubMed
Search for other papers by Miriam Elbracht in
Google Scholar
PubMed
Search for other papers by Thomas Eggermann in
Google Scholar
PubMed
W . A proposal for the interpretation of serum IGF-I concentration as part of laboratory screening in children with growth failure . Journal of Clinical Research in Pediatric Endocrinology 2020 12 130 – 139 . ( https://doi.org/10.4274/jcrpe